Literature DB >> 16298938

Human fibroblast growth factor 20 (FGF-20; CG53135-05): a novel cytoprotectant with radioprotective potential.

T Maclachlan1, B Narayanan, V L Gerlach, G Smithson, R W Gerwien, O Folkerts, E G Fey, B Watkins, T Seed, E Alvarez.   

Abstract

The aim was to evaluate the radioprotective properties of recombinant human fibroblast growth factor 20 (FGF-20; CG53135-05) in vitro and in vivo and to examine its effects on known cellular pathways of radioprotection. Relative transcript levels of the cyclooxygenase 2 (COX2), Mn-super oxide dismutase (SOD), CuZn-SOD, extracellular (EC)-SOD, nuclear respiratory factor 2 (Nrf2), glutathione peroxidase 1 (GPX1) and intestinal trefoil factor 3 (ITF3) genes, which are involved in radiation response pathways, were assessed by reverse transcriptase-polymerase chain reaction (RT-PCR) in NIH/3T3, IEC18, CCD-18Co, CCD-1070sk and human umbilical vein endothelial cells (HUVEC) cells exposed to FGF-20. Activation of the radioprotective signal transduction pathways initiating with the serine/threonine Akt kinase and the extracellular regulated kinase (ERK) were analysed. Levels of intracellular hydrogen peroxide and cytosolic redox potential were also measured in irradiated and unirradiated cells in the presence or absence of FGF-20. The effects of FGF-20 on cell survival in vitro following ionizing radiation were evaluated using clonogenic assays. To test the potential activity of FGF-20 as a radioprotectant in vivo, mice were administered a single dose of FGF-20 (4 mg kg(-1), intraperitoneally (i.p.) 1 day before lethal total-body irradiation and evaluated for survival. In vitro exposure to FGF-20 increased expression of the Nrf2 transcription factor and oxygen radical scavenging enzymes such as MnSOD, activated signal transduction pathways (ERK and Akt) and resulted in increased survival of irradiated cells in vitro. FGF-20 treatment also resulted in a concomitant reduction in intracellular levels of injurious reactive oxygen species (ROS) following acute ionizing irradiation. Finally, prophylactic administration of FGF-20 to mice before potentially lethal, whole-body X-irradiation led to significant increases in overall survival. FGF-20 reduced the lethal effects of acute ionizing radiation exposure in cells by up-regulating important signalling and free radical scavenging pathways. Survival-sparing effects of FGF-20 prophylaxis in acutely irradiated mice presumably are elicited by comparable mechanisms. These results indicate that FGF-20, has significant radioprotective attributes with potential applications in clinical and non-clinical exposure settings.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16298938     DOI: 10.1080/09553000500211091

Source DB:  PubMed          Journal:  Int J Radiat Biol        ISSN: 0955-3002            Impact factor:   2.694


  9 in total

Review 1.  Modifying radiation damage.

Authors:  Kwanghee Kim; William H McBride
Journal:  Curr Drug Targets       Date:  2010-11       Impact factor: 3.465

2.  Homodimerization controls the fibroblast growth factor 9 subfamily's receptor binding and heparan sulfate-dependent diffusion in the extracellular matrix.

Authors:  Juliya Kalinina; Sara A Byron; Helen P Makarenkova; Shaun K Olsen; Anna V Eliseenkova; William J Larochelle; Mohanraj Dhanabal; Steven Blais; David M Ornitz; Loren A Day; Thomas A Neubert; Pamela M Pollock; Moosa Mohammadi
Journal:  Mol Cell Biol       Date:  2009-06-29       Impact factor: 4.272

Review 3.  Towards novel radiosensitizing agents: the role of cytosolic PLA2α in combined modality cancer therapy.

Authors:  Jeffrey M Craft; Dennis Hallahan
Journal:  Future Med Chem       Date:  2011-05       Impact factor: 3.808

4.  Zebrafish stromal cells have endothelial properties and support hematopoietic cells.

Authors:  Troy C Lund; Tiffany J Glass; Arif Somani; Sethu Nair; Jakub Tolar; Mick Nyquist; Xiaobai Patrinostro; Bruce R Blazar
Journal:  Exp Hematol       Date:  2011-09-12       Impact factor: 3.084

5.  Radiation damage and radioprotectants: new concepts in the era of molecular medicine.

Authors:  M I Koukourakis
Journal:  Br J Radiol       Date:  2012-01-31       Impact factor: 3.039

6.  Protective effects of selenocystine against γ-radiation-induced genotoxicity in Swiss albino mice.

Authors:  Amit Kunwar; S Jayakumar; H N Bhilwade; P P Bag; H Bhatt; R C Chaubey; K I Priyadarsini
Journal:  Radiat Environ Biophys       Date:  2011-01-23       Impact factor: 1.925

7.  Selective induction of integrin beta1 by hypoxia-inducible factor: implications for wound healing.

Authors:  Simon Keely; Louise E Glover; Christopher F MacManus; Eric L Campbell; Melanie M Scully; Glenn T Furuta; Sean P Colgan
Journal:  FASEB J       Date:  2008-12-22       Impact factor: 5.191

Review 8.  Radiation countermeasure agents: an update (2011-2014).

Authors:  Vijay K Singh; Victoria L Newman; Patricia L P Romaine; Stephen Y Wise; Thomas M Seed
Journal:  Expert Opin Ther Pat       Date:  2014-10-14       Impact factor: 6.674

9.  Fibroblast growth factor 20 attenuates pathological cardiac hypertrophy by activating the SIRT1 signaling pathway.

Authors:  Yunjie Chen; Ning An; Xuan Zhou; Lin Mei; Yanru Sui; Gen Chen; Huinan Chen; Shengqu He; Cheng Jin; Zhicheng Hu; Wanqian Li; Yang Wang; Zhu Lin; Peng Chen; Litai Jin; Xueqiang Guan; Xu Wang
Journal:  Cell Death Dis       Date:  2022-03-28       Impact factor: 8.469

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.